Fluxion Biosciences Lands $1,500,000 New Round

  • Feed Type
  • Date
  • Company Name
    Fluxion Biosciences
  • Mailing Address
    384 Oyster Point Blvd. #6 San Francisco, CA 94080
  • Company Description
    Fluxion Biosciences has developed the revolutionary CellFlux microfluidics technology for conducting critical research and drug discovery at the cellular level. The CellFlux platform delivers a robust, high-performance, economical solution for single-cell analysis.

    Fluxion develops and markets scientific instruments, software, and consumables which serve the life science research and biopharmaceutical sectors, targeting applications such as cystic fibrosis and leukemia research, antibiotics development, and drug toxicity screening.

  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Kodiak Venture Partners
  • Venture Investor

Trending on Xconomy